SCHEMBL6935944

SCHEMBL6935944

CCCc1c(OC)cc(CC(=O)Cc2cc(OC)c(CCC)c(OC)c2)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C8 P10632 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2B6 P20813 1/20 0.41
CYP2C19 P33261 1/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
ALOX5 P09917 3/20 0.41
HMGCR P04035 1/20 0.41
OR51E2 Q9H255 1/20 0.41
ALDH1A1 P00352 2/20 0.40
GAA P10253 2/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL918362 0.79 HMGCR (0.44) CYP3A4PPARGPPARAALOX5HMGCR
SCHEMBL918847 0.79 PTGS2 (0.59) CYP3A4HMGCRALDH1A1PDE3BPDE3A
SCHEMBL28708164 0.77 ALOX5 (0.56) CYP1A2CYP3A4CYP2C9CYP2B6ALOX5
SCHEMBL7046945 0.77 PTGS2 (0.57) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL919348 0.77 PTGS2 (0.42) CYP3A4HMGCRALDH1A1TSHRPDE3B
SCHEMBL6931161 0.76 PDE3B (0.41) CYP3A4PPARGPPARAHMGCRALDH1A1
SCHEMBL918757 0.76 PGK1 (0.46) CYP3A4PPARGPPARAHMGCRALDH1A1
SCHEMBL918581 0.75 L3MBTL1 (0.48) CYP1A2CYP3A4CYP2C9CYP2C19PPARG
SCHEMBL7114104 0.75 ALOX5 (0.53) CYP3A4ALOX5HMGCRTDP1PDE3B
Hydrochloric Acid SCHEMBL25186690 0.73 HTR2A (0.61) CYP1A2CYP3A4ALDH1A1TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1368306-A1 NOVEL 1,2-DIPHENYLETHENE DERIVATIVES FOR TREATMENT OF IMMUNE DISEASES Welichem Biotech Inc. (CA) 2003-12-10 EP disclosed
WO-2002057219-A1 NOVEL 1,2-DIPHENYLETHENE DERIVATIVES FOR TREATMENT OF IMMUNE DISEASES WELICHEM BIOTECH INC. (CA) 2002-07-25 WO disclosed